PURE study

PURE study is a large, prospective cohort investigation of chronic noncommunicable diseases across diverse global settings. Initiated in the early 21st century, the study enrolled adults from high-, middle-, and low-income countries to examine risk factors for cardiovascular disease, mortality, and related outcomes. Led by cardiologist Salim Yusuf and coordinated by the Population Health Research Institute, the project has produced influential and contested findings about diet, tobacco, medication, and socioeconomic determinants of health.

Background and objectives

The study was launched to address gaps identified by investigators from McMaster University, World Health Organization, International Diabetes Federation, World Heart Federation, and national health agencies in understanding regional variation in chronic disease. Motivated by epidemiologic transitions documented in reports by Global Burden of Disease Study, United Nations, World Bank, Bill & Melinda Gates Foundation analyses, and policy agendas such as the WHO Framework Convention on Tobacco Control, PURE aimed to quantify associations between lifestyle, environmental, and health-system factors and outcomes including myocardial infarction, stroke, cancer, and all-cause mortality. The objectives included characterizing the roles of dietary patterns, tobacco use (including products regulated under WHO FCTC), medication access influenced by agencies like Food and Drug Administration and European Medicines Agency, and sociodemographic gradients observed in studies from Framingham Heart Study and INTERHEART.

Study design and methodology

PURE used a prospective cohort design modeled in part on multinational collaborations such as INTERHEART, Framingham Heart Study, Nurses' Health Study, Health Professionals Follow-up Study, and registry efforts like CARDIA. Enrollment targeted adults aged 35–70 from urban and rural communities with standardized questionnaires adapted from instruments used by WHO STEPS and clinical assessments comparable to protocols from American Heart Association and European Society of Cardiology. Data collection included dietary intake via food frequency questionnaires, biometrics, blood biomarkers processed in laboratories linked to institutions like McMaster University, and outcome adjudication by panels including experts from Royal College of Physicians and national cardiology societies. Statistical methods employed multivariable regression, competing-risks models, and sensitivity analyses referencing techniques popularized in work by Bradford Hill-style causality discussions and methodological guides from STROBE and CONSORT statements. Funding and governance involved partnerships with academic centers in Canada, China, India, Brazil, and other participant countries.

Key findings and results

Major publications from the consortium reported associations between blood pressure, tobacco use (including smokeless tobacco patterns prominent in South Asia), and cardiovascular outcomes, echoing prior findings from INTERHEART and Framingham Heart Study while highlighting regional heterogeneity seen in Global Burden of Disease Study maps. Dietary analyses asserted that higher intake of total fat and animal-derived fats correlated with lower mortality than previously thought, contrasting with dietary guidelines from WHO, dietary recommendations from American Heart Association, and historical interpretations from studies like Seven Countries Study. The study also documented gaps in access to secondary prevention medications, paralleling concerns raised by World Health Organization reports and noncommunicable disease initiatives endorsed at the United Nations General Assembly meetings on NCDs. Several papers addressed socioeconomic gradients, linking community-level development indicators influenced by agencies such as World Bank to incidence of chronic disease and mortality.

Criticisms and controversies

Critiques emerged in editorials and letters from investigators associated with Harvard T.H. Chan School of Public Health, University of Oxford, University of Cambridge, Johns Hopkins University, and commentaries in journals like The Lancet and BMJ. Methodological concerns focused on dietary assessment validity compared with biomarkers used by groups at National Institutes of Health, potential residual confounding noted by epidemiologists trained in frameworks from Bradford Hill, and generalizability given site selection. Debates cited differences with randomized evidence from trials led by investigators at Willett Laboratory and PREDIMED contributors, and questioned interpretation relative to guidelines by American Heart Association and European Society of Cardiology. Transparency and conflicts of interest were discussed in the context of funding mechanisms involving institutions such as Population Health Research Institute and collaborations with national bodies in participant countries.

Impact and implications

Despite controversy, the study has influenced discussions at conferences hosted by World Heart Federation, policy dialogues at the United Nations, and guideline deliberations in organizations like American Heart Association, European Society of Cardiology, and national ministries of health in India and China. The findings have prompted re-examination of dietary policy, tobacco-control priorities under the WHO FCTC, and strategies for medication access championed by groups like the Global Alliance for Chronic Diseases. The consortium’s datasets continue to be used by researchers from institutions such as McMaster University, Harvard University, University of Toronto, and University of Oxford to explore determinants of noncommunicable disease, inform comparative effectiveness work, and shape global health research agendas.

Category:Epidemiology